Modified recombinant human IgG1-Fc is superior to natural intravenous immunoglobulin at inhibiting immune-mediated demyelination.
Baksmeier C, Blundell P, Steckel J, Schultz V, Gu Q, Da Silva Filipe A, Kohl A, Linnington C, Lu D, Dell A, Haslam S, Wang J, Czajkowsky D, Goebels N, Pleass RJ.
Baksmeier C, et al. Among authors: haslam s.
Immunology. 2021 Sep;164(1):90-105. doi: 10.1111/imm.13341. Epub 2021 May 9.
Immunology. 2021.
PMID: 33880776
Free PMC article.